|
|
|
Insider
Information: |
Johnson & Johnson Development Corp Et Al |
Relationship: |
10% Owner |
City: |
New Brunswick |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
15 |
|
Direct
Shares |
10,136,639 |
|
Indirect Shares
|
43,524,732 |
|
|
Direct
Value |
$65,270,298 |
|
|
Indirect Value
|
$357,828,956 |
|
|
Total
Shares |
53,661,371 |
|
|
Total
Value |
$423,099,254 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
1
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
1
|
1
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
-1.0
|
Percentage
Gain/Loss : |
-31.6%
|
-58.7%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Immunicon Corp |
IMMCQ |
10% Owner |
|
0 |
2004-06-10 |
1,771,571 |
Premium* |
|
Universal Biosensors Inc |
UVBIF |
10% Owner |
|
0 |
2011-09-08 |
15,749,937 |
Premium* |
|
Tengion Inc |
TNGN |
10% Owner |
2010-04-14 |
0 |
2010-04-14 |
1,194,654 |
Premium* |
|
Genocea Biosciences, Inc. |
GNCA |
10% Owner |
2014-02-10 |
0 |
2014-03-12 |
1,392,094 |
Premium* |
|
Neurogene |
NGNE |
10% Owner |
2014-03-12 |
0 |
2015-08-11 |
100,000 |
Premium* |
|
Aldeyra Therapeutics, Inc. |
ALDX |
10% Owner |
2014-05-01 |
0 |
2014-05-01 |
1,750,292 |
Premium* |
|
Minerva Neurosciences, Inc. |
NERV |
10% Owner |
|
0 |
2017-08-29 |
0 |
Premium* |
|
Nevro Corp |
NVRO |
10% Owner |
2014-11-12 |
0 |
2015-06-08 |
2,066,740 |
Premium* |
|
Achillion Pharmaceuticals Inc |
ACHN |
10% Owner |
|
0 |
2017-11-20 |
0 |
Premium* |
|
Protagonist Therapeutics, Inc |
PTGX |
10% Owner |
2016-08-16 |
0 |
2016-08-16 |
2,449,183 |
Premium* |
|
Inspire Medical Systems Inc |
INSP |
10% Owner |
2018-05-07 |
0 |
2018-05-07 |
235,251 |
Premium* |
|
Provention Bio Inc |
PRVB |
10% Owner |
2018-07-19 |
0 |
2018-07-19 |
2,400,000 |
Premium* |
|
Fusion Pharmaceuticals Inc. |
FUSN |
10% Owner |
2020-06-30 |
0 |
2020-06-30 |
3,670,516 |
Premium* |
|
Cvrx, Inc. |
CVRX |
|
2023-09-15 |
3,495,575 |
2024-02-29 |
4,103,430 |
Premium* |
|
Meiragtx Holdings Plc |
MGTX |
10% Owner |
2023-09-15 |
6,641,064 |
2022-11-09 |
6,641,064 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
111 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
NGNE |
Neurogene |
10% Owner |
|
2014-11-21 |
4 |
S |
$8.25 |
$19,800 |
I/I |
(2,400) |
1,386,594 |
0 |
- |
|
NGNE |
Neurogene |
10% Owner |
|
2014-11-24 |
4 |
S |
$8.02 |
$32,080 |
I/I |
(4,000) |
1,382,594 |
0 |
- |
|
NGNE |
Neurogene |
10% Owner |
|
2014-11-25 |
4 |
S |
$7.80 |
$11,700 |
I/I |
(1,500) |
1,381,094 |
0 |
- |
|
NGNE |
Neurogene |
10% Owner |
|
2014-11-26 |
4 |
S |
$7.60 |
$3,800 |
I/I |
(500) |
1,380,594 |
0 |
- |
|
NGNE |
Neurogene |
10% Owner |
|
2014-12-01 |
4 |
S |
$7.54 |
$9,048 |
I/I |
(1,200) |
1,379,394 |
0 |
- |
|
NGNE |
Neurogene |
10% Owner |
|
2014-12-03 |
4 |
S |
$7.75 |
$12,609 |
I/I |
(1,627) |
1,377,767 |
0 |
- |
|
NGNE |
Neurogene |
10% Owner |
|
2014-12-04 |
4 |
S |
$7.76 |
$78,166 |
I/I |
(10,073) |
1,367,694 |
0 |
- |
|
NGNE |
Neurogene |
10% Owner |
|
2014-12-05 |
4 |
S |
$7.78 |
$32,676 |
I/I |
(4,200) |
1,363,494 |
0 |
- |
|
NGNE |
Neurogene |
10% Owner |
|
2014-12-08 |
4 |
S |
$7.69 |
$15,380 |
I/I |
(2,000) |
1,361,494 |
0 |
- |
|
NGNE |
Neurogene |
10% Owner |
|
2014-12-09 |
4 |
S |
$7.73 |
$38,650 |
I/I |
(5,000) |
1,356,494 |
0 |
- |
|
NGNE |
Neurogene |
10% Owner |
|
2014-12-10 |
4 |
S |
$7.70 |
$10,010 |
I/I |
(1,300) |
1,355,194 |
0 |
- |
|
NGNE |
Neurogene |
10% Owner |
|
2014-12-11 |
4 |
S |
$7.50 |
$10,163 |
I/I |
(1,355) |
1,353,839 |
0 |
- |
|
NGNE |
Neurogene |
10% Owner |
|
2014-12-12 |
4 |
S |
$7.51 |
$27,374 |
I/I |
(3,645) |
1,350,194 |
0 |
- |
|
NGNE |
Neurogene |
10% Owner |
|
2014-12-16 |
4 |
S |
$7.63 |
$49,648 |
I/I |
(6,507) |
1,343,687 |
0 |
- |
|
NGNE |
Neurogene |
10% Owner |
|
2014-12-17 |
4 |
S |
$7.58 |
$12,075 |
I/I |
(1,593) |
1,342,094 |
0 |
- |
|
NERV |
Minerva Neurosciences, In... |
10% Owner |
|
2015-03-13 |
4 |
B |
$4.81 |
$2,924,013 |
I/I |
607,903 |
4,500,159 |
1.5 |
- |
|
NERV |
Minerva Neurosciences, In... |
10% Owner |
|
2015-03-18 |
5 |
B |
$4.93 |
$2,996,962 |
I/I |
607,903 |
3,892,256 |
0 |
- |
|
NVRO |
Nevro Corp |
10% Owner |
|
2015-06-08 |
5 |
S |
$48.00 |
$48,492,720 |
I/I |
(1,010,265) |
2,066,740 |
0 |
- |
|
NVRO |
Nevro Corp |
10% Owner |
|
2015-06-08 |
4 |
S |
$47.94 |
$48,432,104 |
I/I |
(1,010,265) |
2,066,740 |
0 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
10% Owner |
|
2015-07-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
18,367,346 |
|
- |
|
NGNE |
Neurogene |
10% Owner |
|
2015-08-10 |
4 |
S |
$31.66 |
$7,327,865 |
I/I |
(231,455) |
1,383,366 |
0 |
- |
|
NGNE |
Neurogene |
10% Owner |
|
2015-08-11 |
4 |
S |
$20.74 |
$26,617,011 |
I/I |
(1,283,366) |
100,000 |
0 |
- |
|
PTGX |
Protagonist Therapeutics,... |
10% Owner |
|
2016-08-16 |
4 |
A |
$0.00 |
$0 |
I/I |
1,865,850 |
1,865,850 |
0 |
- |
|
PTGX |
Protagonist Therapeutics,... |
10% Owner |
|
2016-08-16 |
4 |
B |
$12.00 |
$6,999,996 |
I/I |
583,333 |
2,449,183 |
1.5 |
- |
|
NERV |
Minerva Neurosciences, In... |
10% Owner |
|
2017-08-29 |
4 |
D |
$0.00 |
$389 |
I/I |
(3,892,256) |
0 |
0 |
- |
|
111 Records found
|
|
Page 4 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|